Gene therapy of epidermolysis bullosa (Q35873767)

10 August 2017

1 reference

title

Gene therapy of epidermolysis bullosa (English)

1 reference

10 August 2017

0 references

Johann W Bauer

1

1 reference

PubMed ID

15335311

10 August 2017

Martin Laimer

series ordinal

2

1 reference

PubMed ID

15335311

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

9

1 reference

10 August 2017

1435-1443

1 reference

Molecular genetics of heritable blistering disorders

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Isolating a pure population of epidermal stem cells for use in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Capturing and profiling adult hair follicle stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Defining the epithelial stem cell niche in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Virology and immunology of gene therapy, or virology and immunology of high MOI infection with defective viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

21 January 2018

The virtue of tolerance

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Ectopic expression of desmin in the epidermis of transgenic mice permits development of a normal epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Epidermolysis bullosa simplex keratinocytes with extended lifespan established by ectopic expression of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

BP180 gene delivery in junctional epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Tissue-specific expression and long-term deposition of human collagen VII in the skin of transgenic mice: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Stable nonviral genetic correction of inherited human skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in epidermolysis bullosa simplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Inherited dystrophic epidermolysis bullosa in inbred dogs: A spontaneous animal model for somatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Spliceosome-mediated RNA trans-splicing as a tool for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

An algorithm for finding protein-DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Phenotypic suppression and misreading in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis andCFTRStop Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

The future of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1435

10.1517/14712598.4.9.1435

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15335311